First Health United Foundation

First Health United is a non-profit organization based in The Netherlands. We are a fully independent spin off of the company First Health Pharmaceuticals, who transferred the largest part of its antivirus development pipeline to our non-profit foundation.

A Non Profit Organization
The First Health United non-profit organisation was founded with the purpose to promote life science R&D for the benefit of humanity in general. After the foundation of the First Health Capital investment fund and the First Health Pharmaceuticals company, it was decided that a substantial percentage of all future revenues resulting from the DDX3 RNA Helicase antivirus and anti-tumour agents would be redirected towards a dedicated non-profit organisation.
Our Research Focus
We decided to initially and immediately focus on one of the most serious of these viral infections that would at the same time also offer the best perspective for the rapid development of an end product. As such, Severe Dengue was chosen as the first development project of First Health United, trusting that in the future more third world viral diseases will probably benefit from the advancement R&D resulting from the Severe Dengue project.
  • Non Profit Organization
    First Health United Foundation

    We are a fully independent spin off of the company First Health Pharmaceuticals, who transferred the largest part of its antivirus development pipeline to our non-profit foundation

  • Our Mission
    We develop revolutionary new antivirals

    We develop revolutionary new antiviral agents based on an existing portfolio of highly active pharmaceutical compounds that was granted to our organization by our sponsor First Health Pharmaceuticals

  • DDX3 RNA Helicase
    Antivirus and anti-tumour agents

    First Health Pharmaceuticals is a worldwide leader in RNA Helicase technology. The Human DDX3 RNA Helicase is a so-called host factor enzyme needed by many viruses in order to replicate within our cell apparatus. Inhibition of this enzyme effectively blocks viral replication.

  • Severe Dengue
    The first development project of First Health United

    Severe Dengue was chosen as the first development project of First Health United, trusting that in the future more third world viral diseases will probably benefit from the advancement R&D resulting from the Severe Dengue project.

Legal notices

Stichting First Health United
Nonprofit Organization
ADDRESS: Science Park 406 – 1098XH Amsterdam – The Netherlands

LEGAL STATUS: Non-profit foundation with ANBI status

RSIN / Netherlands Fiscal Number: 855838851

NL Business Register: 64780945

IBAN Bank Account: NL96 INGB 0007 7319 08

Contact Person: Dr. Alessia Tarditi Ph.D +31 (0)20 3031921

Email: info@firsthealthunited.org

Board of Directors
Mickey Huibregtsen – President

Jan Willem Bakker – Treasurer

Maurice de Hond – Secretary

Remuneration
Financial compensation for the Board of Directors
Zero. No salaries or compensation of expenses are paid to members of the board of Stichting First Health United
The 2016 Budget
Terms and Policies
Policy of the Foundation
In compliance with the fiscal regulations for non-profit foundations in The Kingdom of The Netherlands, we provide our BELEIDSPLAN (in Dutch language) in the Beleidsplan sub-menu of this website.

Further information about our Mission and Strategy is available on this website